Evaluation of the Abuse Potential of Novel Amphetamine Derivatives with Modifications on the Amine (NBNA) and Phenyl (EDA, PMEA, 2-APN) Sites |
Custodio, Raly James Perez
(Uimyung Research Institute for Neuroscience, Department of Pharmacy, Sahmyook University)
Botanas, Chrislean Jun (Uimyung Research Institute for Neuroscience, Department of Pharmacy, Sahmyook University) Yoon, Seong Shoon (Center for Safety Pharmacology, Korea Institute of Toxicology) de la Pena, June Bryan (Uimyung Research Institute for Neuroscience, Department of Pharmacy, Sahmyook University) dela Pena, Irene Joy (Uimyung Research Institute for Neuroscience, Department of Pharmacy, Sahmyook University) Kim, Mikyung (Uimyung Research Institute for Neuroscience, Department of Pharmacy, Sahmyook University) Woo, Taeseon (Uimyung Research Institute for Neuroscience, Department of Pharmacy, Sahmyook University) Seo, Joung-Wook (Center for Safety Pharmacology, Korea Institute of Toxicology) Jang, Choon-Gon (Department of Pharmacology, School of Pharmacy, Sungkyunkwan University) Kwon, Yong Ho (Department of Life and Nanopharmaceutical Sciences, Kyung Hee University) Kim, Nam Yong (Department of Life and Nanopharmaceutical Sciences, Kyung Hee University) Lee, Yong Sup (Department of Life and Nanopharmaceutical Sciences, Kyung Hee University) Kim, Hee Jin (Uimyung Research Institute for Neuroscience, Department of Pharmacy, Sahmyook University) Cheong, Jae Hoon (Uimyung Research Institute for Neuroscience, Department of Pharmacy, Sahmyook University) |
1 | Marona-Lewicka, D., Rhee, G. S., Sprague, J. E. and Nichols, D. E. (1996) Reinforcing effects of certain serotonin-releasing amphetamine derivatives. Pharmacol. Biochem. Behav. 53, 99-105. DOI |
2 | Matsumoto, T., Maeno, Y., Kato, H., Seko-Nakamura, Y., Monma-Ohtaki, J., Ishiba, A., Nagao, M. and Aoki, Y. (2014) 5-hydroxytryptamine- and dopamine-releasing effects of ring-substituted amphetamines on rat brain: a comparative study using in vivo microdialysis. Eur. Neuropsychopharmacol. 24, 1362-1370. DOI |
3 | McPherson, C. S. and Lawrence, A. J. (2007) The nuclear transcription factor CREB: involvement in addiction, deletion models and looking forward. Curr. Neuropharmacol. 5, 202-212. DOI |
4 | Moore, K. A., Lichtman, A. H., Poklis, A. and Borzelleca, J. F. (1995) -Benzyl-N-methylphenethylamine (BNMPA), an impurity of illicit methamphetamine synthesis: pharmacological evaluation and interaction with methamphetamine. Drug Alcohol Depend. 39, 83-89. DOI |
5 | Robaa, D., Enzensperger, C., Abulazm, S. E., Hefnawy, M. M., El-Subbagh, H. I., Wani, T. A. and Lehmann, J. (2011) Chiral indolo[3,2-f][3]benzazecine-type dopamine receptor antagonists: synthesis and activity of racemic and enantiopure derivatives. J. Med. Chem. 54, 7422-7426. DOI |
6 | Salomon, L., Lanteri, C., Glowinski, J. and Tassin, J. P. (2006) Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neurons. Proc. Natl. Acad. Sci. U.S.A. 103, 7476-7481. DOI |
7 | Taniguchi, M., Yamamoto, Y. and Nishi, K. (2010) A technique combining trifluoroacetyl derivatization and gas chromatography-mass spectrometry to distinguish methamphetamine and its 4-substituted analogs. J. Mass Spectrom. 45, 1473-1476. DOI |
8 | Tettey, J., Wong, Y. L., Levissianos, S., Eichinger, N., Soe, T. N., Kelley, S. and Umapornsakula, A. (2013) Patterns and Trends of Amphetamine-Type Stimulants and Other Drugs: Challenges for Asia and the Pacific. A Report from the Global SMART Programme. pp. 1-162. |
9 | Thanos, P. K., Volkow, N. D., Freimuth, P., Umegaki, H., Ikari, H., Roth, G., Ingam, D. K. and Hitzemann, R. (2001) Overexpression of dopamine D2 receptors reduces alcohol self-administration. J. Neurochem. 78, 1094-1103. DOI |
10 | United Nations Office on Drugs and Crime (2011) Amphetamines and ecstasy. 2011 Global ATS Assessment. United Nations Publication. Available from: https://www.unodc.org/documents/ATS/ATS_Global_Assessment_2011.pdf/. |
11 | United Nations Office on Drugs and Crime (2016) World Drug Report 2016. United Nations publication. Available from: https://www.unodc.org/doc/wdr2016/WORLD_DRUG_REPORT_2016_web.pdf/. |
12 | Vallejos, G., Fierro, A., Renzende, M. C., Sepúlveda-Boza, S. and Reyes-Parada, M. (2005) Heteroarylisopropylamines as MAO inhibitors. Bioorg. Med. Chem. 13, 4450-4457. DOI |
13 | Flomenbaum, N. E., Goldfrank, L. R., Hoffman, R. S., Howland, M. A., Lewin, N. A. and Nelson, L. S. (2006) Goldfrank's Toxicologic Emergencies, 8th edition. McGraw Hill. |
14 | de la Pena, J. B., Yoon, S. Y., de la Pena, I. C., Lee, H. L., de la Pena, I. J. and Cheong, J. H. (2013) Pre-exposure to related substances induced place preference and self-administration of the NMDA receptor antagonist-benzodiazepine combination, zoletil. Behav. Pharmacol. 24, 20-28. DOI |
15 | Drug Enforcement Administration (2011) Drugs of Abuse: 2011 Edition. A DEA Resource Guide. US Department of Justice. |
16 | Funada, M., Aoo, N. and Wada, K. (2014) Rewarding effects of N-methyl-1-(4-Methoxyphenyl)-2-aminopropane (PMMA) in mice: role of modifications of dopamine system mediated through its monoamine oxidase inhibition. J. Addict. Res. Ther. 5, 172. |
17 | Halberstadt, A. L., Powell, S. B. and Geyer, M. A. (2013) Role of the 5-HT2A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice. Neuropharmacology 70, 218-227. DOI |
18 | Kalant, H. (2001) The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. CMAJ 165, 917-928. |
19 | Kang, S., Paul, K., Hankosky, E. R., Cox, C. L. and Gulley, J. M. (2016) D1 receptor-mediated inhibition of medial prefrontal cortex neurons is disrupted in adult rats exposed to amphetamine in adolescence. Neuroscience 324, 40-49. DOI |
20 | Kim, J. Y., Shin, H. S. and In, M. K. (2010) Determination of amphetamine-type stimulants, ketamine and metabolites in fingernails by gas chromatography-mass spectrometry. Forensic Sci. Int. 194, 108-114. DOI |
21 | Lüscher, C. and Malenka, R. C. (2011) Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron 69, 650-663. DOI |
22 | Cain, M. E., Denehy, E. R. and Bardo, M. T. (2008) Individual differences in amphetamine self-administration: The role of the central nucleus of the amygdala. Neuropsychopharmacology 33, 1149-1161. DOI |
23 | Ali, R. (2006) WHO multi-site project on methamphetamine induced psychosis: a descriptive report on findings from participating countries. Drug & Alcohol Services South Australia. |
24 | Berman, S., O'Neill, J., Fears, S., Bartzokis, G. and London, E. D. (2008) Abuse of amphetamines and structural abnormalities in the brain. Ann. N. Y. Acad. Sci. 1141, 195-220. DOI |
25 | Berman, S. M., Kuczenski, R., McCracken, J. T. and London, E. D. (2009) Potential adverse effects of amphetamine treatment on brain and behavior: a review. Mol. Psychiatry 14, 123-142. DOI |
26 | Dean, B. V., Stellpflug, S. J., Burnett, A. M., and Engebretsen, K. M. (2013) 2C or not 2C: phenethylamine designer drug review. J. Med. Toxicol. 9, 172-178. DOI |
27 | Sitte, H. H. and Freissmuth, M. (2015) Amphetamines, new psychoactive drugs and the monoamine transporter cycle. Trends Pharmacol. Sci. 36, 41-50. DOI |
28 | Schatzberg, A. F. and Nemeroff, C. B. (2009) The American Psychiatric Publishing Textbook Of Psychopharmacology. American Psychiatric Pub. |